Patents by Inventor Keisuke Niikura

Keisuke Niikura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230220049
    Abstract: A method for promoting diversification of variable regions of an antibody, particularly a method for promoting diversification of the amino acid sequences of variable regions of an antibody generated by an avian B cell population, the method including suppressing the PI3K? activity of each avian B cell comprised in the avian B cell population expressing the antibody.
    Type: Application
    Filed: January 3, 2023
    Publication date: July 13, 2023
    Inventors: Keisuke Niikura, Yosuke Kamimura
  • Patent number: 11572402
    Abstract: The present invention relates to a method for promoting diversification of variable regions of an antibody. Specifically, the present invention relates to a method for promoting diversification of the amino acid sequences of variable regions of an antibody generated by an avian B cell population, wherein the method comprises suppressing the PI3K? activity of each avian B cell comprised in the avian B cell population expressing the antibody.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: February 7, 2023
    Assignee: CHIOME BIOSCIENCE INC.
    Inventors: Keisuke Niikura, Yosuke Kamimura
  • Patent number: 11535654
    Abstract: The present invention addresses the problem of providing: a fusion protein or conjugated protein having excellent cell membrane permeability, containing a partial peptide derived from human, and suitable for intracellular delivery; an intracellular delivery carrier comprising such a fusion protein or conjugated protein; a partial peptide; a cell membrane permeation enhancer comprising the partial peptide; DNA; and a vector. The fusion protein or conjugated protein has a partial peptide comprising at least seven consecutive amino acid residues of an amino acid sequence encoded by a predetermined DNA, and a ligand directly or indirectly bound to the partial peptide and having the capability of binding to cell surfaces. The ligand is preferably an antibody. The intracellular delivery carrier comprises the fusion protein or conjugated protein. The cell membrane permeation enhancer comprises the partial peptide.
    Type: Grant
    Filed: June 2, 2016
    Date of Patent: December 27, 2022
    Assignee: Keio University
    Inventors: Kei Sudo, Keisuke Niikura, Nobuhide Doi
  • Publication number: 20190359691
    Abstract: The present invention relates to a method for promoting diversification of variable regions of an antibody. Specifically, the present invention relates to a method for promoting diversification of the amino acid sequences of variable regions of an antibody generated by an avian B cell population, wherein the method comprises suppressing the PI3K? activity of each avian B cell comprised in the avian B cell population expressing the antibody.
    Type: Application
    Filed: February 9, 2018
    Publication date: November 28, 2019
    Inventors: Keisuke Niikura, Yosuke Kamimura
  • Publication number: 20180237482
    Abstract: The present invention addresses the problem of providing: a fusion protein or conjugated protein having excellent cell membrane permeability, containing a partial peptide derived from human, and suitable for intracellular delivery; an intracellular delivery carrier comprising such a fusion protein or conjugated protein; a partial peptide; a cell membrane permeation enhancer comprising the partial peptide; DNA; and a vector. The fusion protein or conjugated protein has a partial peptide comprising at least seven consecutive amino acid residues of an amino acid sequence encoded by a predetermined DNA, and a ligand directly or indirectly bound to the partial peptide and having the capability of binding to cell surfaces. The ligand is preferably an antibody. The intracellular delivery carrier comprises the fusion protein or conjugated protein. The cell membrane permeation enhancer comprises the partial peptide.
    Type: Application
    Filed: June 2, 2016
    Publication date: August 23, 2018
    Inventors: Kei Sudo, Keisuke Niikura, Nobuhide Doi